Latest European Union News

Osmond Resources is fast-tracking development of its Orión EU Critical Minerals Project, with initial drilling confirming high-grade titanium, zircon, and rare earth elements. The company aims to complete a maiden Mineral Resource Estimate and Scoping Study by mid-2026.

Osmond Resources has raised A$6.6 million through a discounted placement to fund its 2026 work program targeting titanium, zircon, and rare earth extraction in Spain. The capital boost positions the company to progress its Orión EU Critical Minerals Project amid growing EU demand for local supply.

Imricor Medical Systems has achieved a major milestone with FDA clearance for its Vision-MR Diagnostic Catheter, paving the way for commercial sales in the US electrophysiology market.

Kalamazoo Resources has initiated a $2 million underwritten Share Purchase Plan, offering eligible shareholders shares at a 16.4% discount to recent prices. The offer aims to fund exploration and development activities across its Victorian and Western Australian projects.

Sprintex Limited has landed its largest-ever €15.6 million order for ZLD-UP® manure processing systems, marking a pivotal shift from evaluation to commercial deployment across Europe. This multi-year contract sets the stage for substantial revenue growth and a path to profitability in FY26.

Memphasys has secured CE Mark approval for its Felix™ sperm selection system, enabling full commercial rollout across Europe and activating multi-year contracts worth over A$1.3 million. This milestone signals the company’s transition into a revenue-scaling phase with global growth ambitions.

European Metals Holdings has released a Definitive Feasibility Study confirming the Cinovec Lithium Project as a long-life, battery-grade lithium carbonate producer strategically positioned to supply Europe's electric vehicle and energy storage sectors.

TrivarX has received $3.5 million in second-tranche placement funding, enabling advancement of its innovative Stabl-Im technology for early, non-invasive brain tumour detection. The funding supports manufacturing scale-up and regulatory preparations ahead of a planned Phase 1 clinical trial in 2026.

Neuren Pharmaceuticals has secured Health Canada approval to expand its pivotal Phase 3 trial of NNZ-2591 for Phelan-McDermid syndrome into Canadian sites, complementing ongoing US enrolment.

EIT RawMaterials has committed an additional €1.5 million to advance the Finnish Vanadium Recovery Project, reinforcing its role in Europe's critical materials supply chain. This marks the third funding round supporting technical innovation and project financing efforts.

Sarytogan Graphite Limited updates investors on its $5 million capital raising, highlighting regulatory approval delays but confirming near-term funding to advance its key graphite project.

Memphasys Limited’s partner International Technical Legacy has placed an early order for 500 Felix™ cartridges ahead of anticipated CE Mark approval, signalling strong clinic demand and validating the company’s direct-selling strategy in the Middle East.